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(o the Editor: The incremental value of myocardial ischemia
ssessed by dobutamine stress echocardiography (DSE) for pre-
icting cardiac events has been shown in various patient groups (1).
he clinical utility of non-invasive stress testing has been mostly
stablished among patients with intermediate pre-test probability
f coronary artery disease (CAD). In patients with a low pre-test
robability of CAD, exercise echocardiography was shown to
rovide limited prognostic information and was not routinely
ecommended (2). There are currently insufficient data to suggest
prognostic role of myocardial ischemia assessed by stress echo-
ardiography in patients with typical angina who are determined to
ave a high pre-test probability of CAD. According to the Bayes
heorem, a normal stress test result in these patients only
odestly reduces the post-test probability of CAD. Therefore,
t is not known whether patients with a high pre-test probability
f CAD would be considered a low-risk population if they had
normal stress echocardiogram. We sought to assess the
dditional value of myocardial ischemia during DSE in predict-
Table 1. Predictors of Events by Cox Models
Parameter
Cardiac death
Clinical model
Age
Male gender
Heart failure
Systemic hypertension
Stress echocardiographic model
Resting heart rate
Resting wall motion abnormalities
Ischemia
All-cause mortality
Clinical model
Age
Male gender
Heart failure
Systemic hypertension
Stress echocardiographic model
Resting heart rate
ST-segment depression on electrocardiogram du
Resting wall motion abnormalities
Ischemia
Hard cardiac events
Clinical model
Age
Male gender
Heart failure
Systemic hypertension
Echocardiographic model
Resting heart rate
Resting wall motion abnormalities
IschemiaCI  confidence interval; RR  risk ratio.ng mortality and hard cardiac events in patients with angina
nd no history of CAD.
The study population consisted of consecutive patients with typical
ngina who were considered to have a high pre-test probability of
AD (0.7) referred for DSE. This was considered in the presence
f typical angina pectoris in women50 years of age and in men30
ears of age, according to the published data (3). Patients were
xcluded if they had a previous myocardial infarction, myocardial
evascularization, or significant coronary artery stenosis by angiog-
aphy. Criteria were fulfilled in 329 patients. The protocol was
pproved by the Hospital Ethics Committee. Follow-up was
uccessful in 327 patients (99%); 28 (8%) underwent early coronary
evascularization (within 60 days after the DSE).
The DSE was performed and interpreted according to a
tandard protocol as previously reported (1). An abnormal test
esult was defined as resting wall motion abnormality or ischemia.
ollow-up events were overall mortality and hard cardiac events
nonfatal myocardial infarction and cardiac death).
Univariate RR Multivariate RR
(CI) (CI)
1.05 (1.02–1.09) 1.06 (1.03–1.10)
1.8 (1.1–3.2) 3.2 (1.5–6.7)
3.4 (1.7–6.8) —
1.2 (1.1–1.8) 1.9 (1.1–3.6)
1.02 (1.01–1.05) 1.03 (1.01–1.05)
1.9 (1.1–3.2) 1.9 (1.1–3.7)
2.5 (1.4–4.2) 2.5 (1.3–4.8)
1.06 (1.03–1.09) 1.07 (1.05–1.10)
1.4 (1.1–2.0) 2.1 (1.3–3.5)
2.1 (1.3–3.5)
1.2 (1.1–1.7) 1.6 (1.1–2.6)
1.02 (1.01–1.12) 1.03 (1.01–1.05)
stress 1.2 (1.1–2.0) 2.1 (1.1–4.3)
1.3 (1.1–1.8) —
1.5 (1.1–2.2) 1.6 (1.1–2.6)
1.04 (1.01–1.07) 1.04 (1.01–1.07)
2.0 (1.2–3.2) 2.8 (1.5–5.3)
2.1 (1.1–3.9) —
1.2 (1.1–1.9) 1.9 (1.1–3.3)
1.01 (1.00–1.03) 1.03 (1.01–1.05)
1.5 (1.1–2.4) —
2.4 (1.6–3.8) 3.3 (1.9–5.7)ring
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August 16, 2005:730–42The mean age was 64  10 years. There were 205 (63%)
en. Thirty-six (11%) patients had a history of diabetes
ellitus, 100 (31%) had hypertension, and 24 (7%) had a
istory of heart failure. The target heart rate was reached in 262
80%) patients.
The DSE was normal in 125 (38%) patients. Fixed wall motion
bnormalities were detected in 53 (16%) and ischemia was detected
n 149 (46%) patients. During a mean follow-up of 6  3.8 years,
here were 89 (27%) deaths, of which 52 (16%) were attributed to
ardiac causes. Twenty-one (6%) patients experienced nonfatal
yocardial infarction. Twenty-five of 125 patients with a normal
tress test result (20%) underwent revascularization, whereas 75 of
02 patients with an abnormal test result (37%) underwent
evascularization (p 0.002). Cox proportional hazards regression
nalysis for the end points of cardiac death, hard cardiac events,
nd all-cause mortality is presented in Table 1. The presence of
yocardial ischemia was an independent predictor for all end
oints.
Kaplan-Meier survival curves for the end point cardiac death are
resented in Figure 1. The annual cardiac death, all cause mortal-
ty, and hard cardiac event rates at 5 years were 1.5%, 2.6%, and
.3% in patients with a normal test result and 3.6%, 5.5%, and
.4% in patients with an abnormal DSE result, respectively.
An additional analysis was performed excluding patients with
arly revascularization. This analysis of 299 patients showed that
yocardial ischemia was an independent predictor for cardiac
eath (risk ratio [RR], 2.7; confidence interval [CI], 1.2 to 5.7),
ll-cause mortality (RR, 2.3; CI, 1.4 to 3.8), and hard cardiac
vents (RR, 4.3; CI, 2.3 to 8.1).
In this study, DSE added independent prognostic information
n patients with angina and a high pre-test probability of CAD.
atients with a normal DSE had a lower risk of death and hard
ardiac events, whereas in patients with an abnormal DSE, the
ncidence of all events was substantially higher. The presence of
yocardial ischemia was the strongest independent predictor for
ll end points and was associated with an increased risk of events
fter adjustment to clinical data.
The prevalence of CAD in patients who present with typical
ngina is expected to be approximately 90% for men and 70% for
omen (4). In this study, however, DSE was normal in 38% of the
opulation. The results of our study indicate that patients with a
ormal DSE have a low event rate during intermediate to
ong-term follow-up, and therefore these patients, who represent a
igure 1. Kaplan-Meier survival curves (end point of cardiac death) in
atients with high pre-test probability of coronary artery disease. DSE 
obutamine stress echocardiography.elatively large proportion of the study population, can be ex-mpted from further (invasive) diagnostic evaluation unless a
hange in clinical status occurs.
Few studies evaluated the prognostic value of stress echocardi-
graphy in patients with a high pre-test probability of CAD.
hese studies used composite end points that include soft events
uch as unstable angina and revascularization (5,6), or were not
owered enough to show an incremental value of myocardial
schemia alone (7). A recent study by Hachamovitch et al. (8)
howed that myocardial perfusion imaging provided incremental
rognostic information for predicting cardiac death in 1,270
atients with a high likelihood of CAD who underwent exercise or
denosine stress myocardial perfusion tomography.
Although patients were determined to have a high pre-test
robability of CAD in our study, the annual hard cardiac event rate
as moderate (4%). This can be explained by the exclusion of
atients with previous myocardial infarction, unstable symptoms,
nd a history of CAD, which resulted in inclusion of a stable
opulation with preserved left ventricular systolic function. Al-
hough this study excluded patients with cardiomyopathy, the
ossible existence of other cardiac conditions that may be associ-
ted with cardiac death without ischemia, such as cor pulmonale,
ay have been confounding. However, the incremental signifi-
ance of myocardial ischemia was demonstrated despite this
otential limitation.
We conclude that in patients with classic angina, determined to
ave a high pre-test probability of CAD, DSE yields independent
rognostic information. A negative DSE is associated with a
elatively low event rate for cardiac and all-cause mortality as well
s for the combined end point of hard cardiac events. These
ndings have important clinical implications because these patients
an be exempted from invasive studies if they have no change in
linical status. Myocardial ischemia during DSE is independently
ssociated with an increased risk of death after adjustment for
linical data.
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but no known CAD. J Am Coll Cardiol 2004;43:200–8.A Randomized Trial Comparing 1 mg of Oral Vitamin K With No Treatment in the
y in Patients With Mechanical Heart Valveso the Editor: A strong relationship exists between the risk of
emorrhage and the degree of prolongation of the international
ormalized ratio (INR) in patients receiving warfarin, particularly
hen the INR exceeds 6.0 (1). Simply withholding warfarin is
ikely to be associated with a low, but clinically important, risk of
ajor or life-threatening hemorrhage (1,2). The oral administra-
ion of low doses of vitamin K has been shown to safely and
ffectively reduce the INR toward the normal range in patients
resenting with INR values 4.5 (3–5). In patients with mechan-
cal heart valves, there is a safety concern with the use of vitamin
because overcorrection of the INR may cause thrombosis. The
urpose of this study was to demonstrate that the oral adminis-
ration of low-dose vitamin K is an effective and safe treatment for
atients with mechanical heart valves who present with excessive,
arfarin-associated, anticoagulant effect.
Patients with mechanical heart valves who were receiving
arfarin therapy and who presented with INR values between 6.0
nd 12.0 were allocated randomly to receive either 1 mg of vitamin
administered orally (Phytomenadione, Konakion, Roche, Milan,
taly, or Phytonadione, Mephyton, Merck & Co. Inc., West Point,
ennsylvania) or no treatment. Patients were excluded in the
resence of elevated INR value determined more than 12 h before
creening; high risk of hemorrhage; major non-orthopedic surgery
ithin the past week; thrombocytopenia (platelet count 50 
09/l); indication for acute reversal of anticoagulation; termination
f anticoagulation; receipt of vitamin K or plasma in the 48-h
eriod before enrollment; allergy or sensitivity to vitamin K or
lasma or other contraindication to vitamin K therapy; severe liver
isease; geographic inaccessibility or inability to comply with
equirements for blood work; or failure to obtain informed
onsent.
The day of randomization and study drug administration was
efined as day 0. All patients underwent INR measurement on the
ay after study intervention (day 1). We determined INR values
sing standard local laboratory techniques. In particular, the
ollowing thromboplastin reagents were used: Innovin by Dade
ehring (Milan, Italy; ISI 1.03) at study locations in Varese and in
eggio Emilia, Italy, and Neoplastine by Diagnostica Stago
Parsipanny, New Jersey; ISI 1.27) at the study location in
lbuquerque, New Mexico.
Warfarin therapy was restarted once the INR was in the target
ange, as determined by the attending physician. Patients were
linically followed-up on day 5  1 and were subsequentlyo determine whether thromboembolic or hemorrhagic events had
ccurred.
Analysis was based on the principle of intention to treat. For the
rimary analysis, the proportion of patients with INR values
etween 2.3 and 3.7 on day 1 was determined and compared using
he Fisher exact test. The primary safety analysis was an analysis of
he number of patients who received vitamin K who developed an
NR value of 1.8 on day 1 and also was performed using the
isher exact test. The value of 1.8 was chosen as a “lower limit” for
he INR because this represents a value below which many
hysicians would be concerned that there is a substantially in-
reased risk of thromboembolism. Baseline data were compared
sing the Student t test.
We calculated that we would need to enroll 48 patients per arm
o reliably demonstrate that oral vitamin K was more effective than
imple warfarin withdrawal. We assumed a binomial distribution
nd conservative “success” rates of 40% and 10% in the “oral
itamin K” and “no treatment” arms, respectively, because a sample
ize of 96 would be adequate to achieve power of 90% and alpha
.05. Institutional review board approval was obtained at all
articipating centers.
Between September 2002 and October 2004, 59 patients
rovided informed consent for the study. In October 2004, the
tudy was prematurely stopped because a multinational study
xamining the utility of oral vitamin K, using clinical end points as
able 1. Baseline Characteristics
Vitamin K No Treatment p Value
umber 29 30 —
ean age (yrs) 66 63 NS
ge range (yrs) 31–88 30–83 —
ales 16 11 NS
utpatients 29 30 —
itral prosthetic valve 13 16 NS
ortic prosthetic valve 17 16 NS
itral and aortic
position
1 2 NS
oncomitant atrial
fibrillation
10 9 NS
oncomitant heparin
treatment
0 0 NS
revious bleeding 7 5 NS
revious asymptomatic
INR elevation
20 18 NSNR  international normalized ratio; NS  not significant.
